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Abstract 
DNA damage blocks the progression of the replication fork. In order to circumvent 
the damaged bases, cells employ specialised low stringency DNA polymerases, which 
are able to carry out translesion synthesis (TLS) past different types of damage. The 
five polymerases used in TLS in human cells have different substrate specificities, 
enabling them to deal with many different types of damaged bases. PCNA plays a 
central role in recruiting the TLS polymerases and effecting the polymerase switch 
from replicative to TLS polymerase. When the fork is blocked PCNA gets 
ubiquitinated. This increases its affinity for the TLS polymerases, which all have 
novel ubiquitin-binding motifs, thereby facilitating their engagement at the stalled 
fork to effect TLS.
Introduction 
The ability of all organisms to replicate their genomes is a pre-requisite for life. In 
order to accomplish this with maximum efficiency and fidelity, organisms have 
evolved superbly tailored replication machines. Central to these machines are 
replicative DNA polymerases, which are able to replicate DNA at high speed, with 
high processivity and with a very low error-rate. High fidelity is achieved by the 
active sites of these polymerases having stringent requirements, matching the 
incoming nucleotide to the template base by the appropriate Watson-Crick base-
pairing. In addition the 3’-5’ exonucleases associated with replicative polymerases 
remove any base that might, on rare occasions, be mis-inserted. DNA is however 
subject to continual damage from both endogenous and exogenous sources, and 
although most types of damage are removed by the cellular repair machinery, these 
processes are often slow and incomplete. Damage often remains in the DNA during 
replication and the price paid for the efficiency and accuracy of replicative 
polymerases is that many types of damage block their progress. An important 
mechanism for overcoming these blocks, particularly in mammalian cells, entails the 
use of specialised DNA polymerases to carry out translesion synthesis (TLS) past the 
damaged sites. Most of these polymerases belong to the Y-family [1], and in contrast 
to the replicative polymerases, they operate at low speed, low processivity and with 
low fidelity. However because their active sites adopt a much more open structure 
than replicative polymerases, they are less stringent and can accommodate altered 
bases in their active sites (eg see [2]). There are two Y-family polymerases in 
Escherichia coli (Polymerases IV and V), two in Saccharomyces cerevisiae (Polη and 
Rev1) and four in mammalian cells (Pols η, ι, κ and Rev1). In addition, the B-family 
DNA polymerase ζ also plays an important role in TLS in eukaryotes. The conserved 
active site structure of the Y-family polymerases is usually located in the N-terminal 
two-thirds of the protein. The C-terminal third is not conserved between the different 
Y-family polymerases and is involved with localisation, recruitment and protein-
protein interactions (see below). 
 
TLS polymerases 
Polη was discovered in mammalian cells as the protein deficient in the variant form of 
the skin cancer-prone genetic disorder xeroderma pigmentosum (XP) [3, 4]. Most XP 
patients are deficient in the ability to remove UV photoproducts from their DNA by 
nucleotide excision repair (NER), but about 20 % are normal in this respect and have 
problems in replicating their DNA after UV-irradiation [5]. The gene defective in 
these XP variants encodes polη. In vitro polη is able to replicate past a cyclobutane 
dimer (CPD), the major UV photoproduct, as efficiently as past undamaged bases, 
and in the majority of cases the “correct” bases are inserted [6, 7]. Because of its poor 
processivity, polη is likely to dissociate relatively soon after it has bypassed the 
damage [7]– an important requirement because of its low fidelity on undamaged 
DNA. XP variant cells have an elevated UV-induced mutation frequency [8], 
indicating that in normal cells polη plays an important role in maintaining mutations 
at a low level on exposure to UV light. In its absence, it is likely that TLS is carried 
out by one of the other TLS polymerases, or more than one acting in combination. 
They are less effective than polη in carrying out this task, resulting in an elevated 
mutation frequency in polη-defective XP variants. The nature of this back-up process 
has been the subject of speculation, based on the in vitro properties of the 
polymerases (eg polι and polζ acting in concert), but convincing evidence is lacking 
at present. Polη is likely to have evolved to carry out TLS past CPD photoproducts 
generated by exposure to sunlight. It can also carry out TLS past some other lesions in 
vitro (eg see [6]) with reduced efficiency, but whether it also does so in vivo is 
uncertain (eg see [9]) 
 
The other major UV lesion, the pyrimidine (6-4) pyrimidone photoproduct, generates 
a much greater distortion in DNA than the CPD and cannot be bypassed by polη. 
Studies in yeast and human cells have indicated that polζ and Rev1 are required for 
TLS past this lesion [10, 11], but the mechanism is not yet understood. 
 
Our understanding of the roles of the other TLS polymerases in vivo is much less 
advanced. Many in vitro studies have been carried out using different damaged DNA 
substrates, and it has been concluded that some of the polymerases are more effective 
at inserting nucleotides across from damaged bases but are unable to extend from the 
inserted nucleotide (eg polι), whereas others are less efficient at this insertion step but 
can extend from a nucleotide inserted by another polymerase opposite a damaged 
base. Both in vivo and in vitro studies have shown that polκ can carry out TLS past 
DNA containing benzo[a]pyrene –guanine adducts [12, 13].  
 
Polζ is a heterodimer containing the Rev3 catalytic subunit and the Rev7 regulatory 
subunit [14]. Rev1, Rev3 and Rev7 were originally identified in S. cerevisae as being 
required for mutations induced by most DNA damaging agents [15]. A similar 
requirement has also been found in human cells  [16, 17]. This implies that they are 
involved in TLS, often inserting the “wrong” bases.  
 
Rev1 is an enigmatic protein. It is not a polymerase, but a dCMP transferase, inserting 
a dCMP residue in a template-directed manner [18]. In the crystal structure, the 
incoming dCTP pairs with an arginine in the active site [19]. However there is 
convincing evidence that this catalytic activity is not required for UV mutagenesis 
[20], although it is required for bypass past other lesions. The properties of rev1, rev3 
and rev7 mutants are in most cases identical, suggesting that polζ and Rev1 act in 
concert. 
 
Localisation 
All the Y-family polymerases are localised in the nucleus, and during S phase, polη, ι 
and Rev1 relocate to replication factories, visible as bright fluorescent foci if the 
polymerases are tagged with green fluorescent protein (eg [21]). Here they colocalise 
with the polymerase sliding clamp PCNA, and other proteins involved in or 
associated with DNA replication. Thus during replication, they are present in the 
environment where replication is taking place, presumably “on stand-by” in case they 
are required. It is often suggested that this poses a danger to the cell, which might 
recruit one of these low fidelity polymerases to replicate the DNA. However, under 
normal circumstances, because of its high processivity it is unlikely that the 
replicative polymerase will be displaced by one of the other polymerases [22]. 
 
Recruitment to the replication fork 
We can then pose the opposite question, namely how are the TLS polymerases 
recruited to the replication fork when the replication machinery is blocked? This 
replacement of replicative with TLS polymerase is designated the “polymerase 
switch”.  A seminal paper by Jentsch and co-workers identified the central role of 
PCNA in the polymerase switch [23]. They showed that in S. cerevisiae, when the 
replication fork was blocked, in this case by damage inflicted by methyl 
methanesulfonate, PCNA became modified by ubiquitination on lysine-164. This 
ubiquitination was effected by the products of genes which had long been known to 
be involved in replication of damaged DNA, but whose role had up till then not been 
understood. The mono-ubiquitination of PCNA was carried out by the E2 ubiquitin-
conjugating enzyme Rad6 and the E3 ubiquitin ligase Rad18. Further ubiquitin 
molecules were added in a lysine-63 linkage by the E2 heterodimer Mms2-Ubc13 and 
the E3 Rad5. It was proposed that mono-ubiquitination channelled the damage 
through an error-prone TLS pathway, whereas poly-ubiquitination channelled into an 
error-free pathway of damage avoidance [23, 24]. This latter pathway has been 
postulated to involve a copy choice type of recombination involving template 
switching, but it is poorly understood and will not be discussed further. 
 
How might ubiquitination of PCNA channel events into a TLS pathway? In 
mammalian cells mono-ubiquitination of PCNA is easily detected after a variety of 
treatments which block the progression of the replication fork, and this is dependent 
on the orthologs of Rad6 and Rad18 [25, 26]. Poly-ubiquitination of PCNA has been 
very hard to detect. A further interesting feature of the regulation of PCNA 
ubiquitination following exposure to DNA damaging treatment is its association with 
the degradation of the de-ubiquitinating enzyme (DUB) USP1 [27], which is able to 
remove mono-ubiquitin from PCNA. Thus DNA damaging treatments result in both 
the activation of proteins that ubiquitinate PCNA (Rad6 and Rad18) and the 
degradation of the protein that de-ubiquitinates it (USP1). 
 
Polymerases η, ι and κ all have classical PCNA-binding “PIP” motifs, and have been 
shown to bind PCNA in vitro (eg see [28, 29]), but not in vivo. This suggests that the 
interactions are weak. Mono-ubiquitination of PCNA increased its affinity for polη, 
so that their interaction could be detected in cell extracts [25, 26]. It was shown 
subsequently that not only polη, but also polι, Rev1 and polκ have novel ubiquitin-
binding domains (UBDs), and that at least in the case of polη and polι (and likely for 
polκ and Rev1 also), the polymerases were able to bind to ubiquitin [30]. Thus, the 
combination of binding to ubiquitinated PCNA via both the PIP motif and the UBDs 
strengthens the interactions between the polymerases and PCNA, facilitating their 
recruitment to the stalled fork and facilitating the polymerase switch.  
 
In vitro replication assays have shown that ubiquitination of PCNA did not alter its 
properties as a processivity factor for the replicative polδ or polε, or for polη on an 
undamaged template. However when the template contained an abasic site, 
ubiquitination of PCNA substantially increased the efficiency of TLS by polη and 
Rev1 [31].  
 
Weak interactions have also been identified between the polymerases themselves. 
Pols η and ι interact directly with each other, and this interaction facilitates the 
localisation of polι into replication factories [21]. Rev1 interacts with polη, ι, κ and 
Rev7, in all cases via the same domain contained in its C-terminal 150 aa [32-34]. It 
should also be borne in mind that PCNA is a homotrimer, and the available evidence 
suggests that ubiquitination is an all or nothing process, ie that all three monomers 
become ubiquitinated in one trimer [25, 31]. Each monomer may therefore be able to 
interact with a different polymerase, providing a “toolbelt” of different polymerases 
that can attempt to deal with the blocked fork [35] (Figure 1A). Thus a medley of 
weak interactions occurs at the stalled fork enabling the polymerases to bind and 
attempt to carry out TLS (summarised in Figure 1B). In the case of a blocking CPD, 
polη will do the job. With other lesions other polymerases will be able to effect TLS. 
In the case of a fork stalled by hydroxyurea, which results in depletion of 
deoxynucleotides, PCNA is ubiquitinated, but none of the polymerases will be able to 
relieve the situation significantly because of the lack of their crucial substrate.  
 
Concluding remarks 
Mammalian cells have evolved a variety of specialised polymerases in order to carry 
out TLS, either singly or in combination, past different types of DNA damage. Their 
recruitment to stalled replication forks requires the modification of PCNA by 
ubiquitination and is regulated by a series of weak interactions between the each 
polymerase and ubiquitinated PCNA and between the polymerases themselves. 
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Figure Legend 
Figure 1 Interactions between polymerases and PCNA 
A, A PCNA trimer at a fork stalled by a lesion (black rectangle). All three monomers 
are ubiquitinated and are shown interacting with different polymerases. B, Summary 
of interactions, indicated by double-headed arrows. 
 
 
 
